100 related articles for article (PubMed ID: 8368486)
1. Reversibility of cysteine labeling by 4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole.
Treuheit MJ; Kirley TL
Anal Biochem; 1993 Jul; 212(1):138-42. PubMed ID: 8368486
[TBL] [Abstract][Full Text] [Related]
2. Suppression of thiol exchange reaction in the determination of reduced-form thiols by high-performance liquid chromatography with fluorescence detection after derivatization with fluorogenic benzofurazan reagent, 7-fluoro-2,1,3-benzoxadiazole-4-sulfonate and 4-aminosulfonyl-7-fluoro-2,1,3-benzoxadiazole.
Santa T; Aoyama C; Fukushima T; Imai K; Funatsu T
Biomed Chromatogr; 2006; 20(6-7):656-61. PubMed ID: 16779773
[TBL] [Abstract][Full Text] [Related]
3. Removal of the fluorescent 4-(aminosulfonyl)-2,1,3-benzoxadiazole label from cysteine-containing peptides.
Lauren SL; Treuheit MJ
J Chromatogr A; 1998 Mar; 798(1-2):47-54. PubMed ID: 9542125
[TBL] [Abstract][Full Text] [Related]
4. Fluorogenic derivatization reagents suitable for isolation and identification of cysteine-containing proteins utilizing high-performance liquid chromatography-tandem mass spectrometry.
Masuda M; Toriumi C; Santa T; Imai K
Anal Chem; 2004 Feb; 76(3):728-35. PubMed ID: 14750869
[TBL] [Abstract][Full Text] [Related]
5. Optimized method for determining free L-cysteine in rat plasma by high-performance liquid chromatography with the 4-aminosulfonyl-7-fluoro-2,1,3-benzoxadiazole conversion reagent.
Otani L; Ogawa S; Zhao Z; Nakazawa K; Umehara S; Yoshimura E; Chang SJ; Kato H
Biosci Biotechnol Biochem; 2011; 75(11):2119-24. PubMed ID: 22056437
[TBL] [Abstract][Full Text] [Related]
6. Amino acid composition analysis of minute amounts of cysteine-containing proteins using 4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole and 4-fluoro-7-nitro-2,1,3-benzoxadiazole in combination with HPLC.
Toyo'oka T; Miyano H; Imai K
Biomed Chromatogr; 1986 Feb; 1(1):15-20. PubMed ID: 3506813
[TBL] [Abstract][Full Text] [Related]
7. Chiral separation of homocysteine by derivatization with 4-aminosulfonyl-7-fluoro-2,1,3-benzoxadiazole followed by capillary electrophoresis using gamma-cyclodextrin.
Kim IJ; Park SJ; Kim HJ
J Chromatogr A; 2000 Apr; 877(1-2):217-23. PubMed ID: 10845800
[TBL] [Abstract][Full Text] [Related]
8. Fluorogenic and fluorescent labeling reagents with a benzofurazan skeleton.
Uchiyama S; Santa T; Okiyama N; Fukushima T; Imai K
Biomed Chromatogr; 2001 Aug; 15(5):295-318. PubMed ID: 11507712
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of a fluorogenic reagent for proteomic studies: 7-fluoro-N-[2-(dimethylamino)ethyl]-2,1,3-benzoxadiazole-4-sulfonamide (DAABD-F).
Koshiyama A; Imai K
Analyst; 2010 Aug; 135(8):2119-24. PubMed ID: 20539882
[TBL] [Abstract][Full Text] [Related]
10. Reduction and fluorescent labeling of cyst(e)ine-containing proteins for subsequent structural analyses.
Kirley TL
Anal Biochem; 1989 Aug; 180(2):231-6. PubMed ID: 2554752
[TBL] [Abstract][Full Text] [Related]
11. Structural analysis of the sheath of a sheathed bacterium, Leptothrix cholodnii.
Takeda M; Makita H; Ohno K; Nakahara Y; Koizumi J
Int J Biol Macromol; 2005 Oct; 37(1-2):92-8. PubMed ID: 16214212
[TBL] [Abstract][Full Text] [Related]
12. 4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole is not specific for labeling of sulfhydryl groups in proteins as it may also react with phenolic hydroxyl groups and amino groups.
Husted LB; Sørensen ES; Sottrup-Jensen L
Anal Biochem; 2003 Mar; 314(1):166-8. PubMed ID: 12633619
[No Abstract] [Full Text] [Related]
13. Allosteric inhibition of PTP1B activity by selective modification of a non-active site cysteine residue.
Hansen SK; Cancilla MT; Shiau TP; Kung J; Chen T; Erlanson DA
Biochemistry; 2005 May; 44(21):7704-12. PubMed ID: 15909985
[TBL] [Abstract][Full Text] [Related]
14. Fluorescein as a versatile tag for enhanced selectivity in analyzing cysteine-containing proteins/peptides using mass spectrometry.
Chen SH; Hsu JL; Lin FS
Anal Chem; 2008 Jul; 80(13):5251-9. PubMed ID: 18512949
[TBL] [Abstract][Full Text] [Related]
15. Effects of fluorescent probe structure on the dynamics at cysteine-34 within bovine serum albumin: evidence for probe-dependent modulation of the cybotactic region.
Baker GA; Pandey S; Kane MA; Maloney TD; Hartnett AM; Bright FV
Biopolymers; 2001 Dec; 59(7):502-11. PubMed ID: 11745116
[TBL] [Abstract][Full Text] [Related]
16. Analysis of local polarity change around Cys34 in bovine serum albumin during N-->B transition by a polarity-sensitive fluorescence probe.
Wang X; Guo L; Ma H
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Sep; 73(5):875-8. PubMed ID: 19451019
[TBL] [Abstract][Full Text] [Related]
17. Carbamylation of cysteine: a potential artifact in peptide mapping of hemoglobins in the presence of urea.
Lippincott J; Apostol I
Anal Biochem; 1999 Feb; 267(1):57-64. PubMed ID: 9918655
[TBL] [Abstract][Full Text] [Related]
18. Identification of 2-(cysteinyl)amido-2-deoxy-D-galacturonic acid residue from the sheath of Leptothrix cholodnii.
Makita H; Nakahara Y; Fukui H; Miyanoiri Y; Katahira M; Seki H; Takeda M; Koizumi J
Biosci Biotechnol Biochem; 2006 May; 70(5):1265-8. PubMed ID: 16717434
[TBL] [Abstract][Full Text] [Related]
19. Proteomics approaches to study the redox state of cysteine-containing proteins.
Camerini S; Polci ML; Bachi A
Ann Ist Super Sanita; 2005; 41(4):451-7. PubMed ID: 16569913
[TBL] [Abstract][Full Text] [Related]
20. The use of tributylphosphine and 4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole in the study of protein sulfhydryls and disulfides.
Chin CC; Wold F
Anal Biochem; 1993 Oct; 214(1):128-34. PubMed ID: 8250214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
